Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Supernus Pharmaceuticals
Business Segments
Products & Services
Revenue recognized
Revenue recognized
Supernus Pharmaceuticals
·
Products & Services
·
1 segment
·
Rolls up to
Revenue recognized that was included in deferred income at the beginning of the period
Breakdown
Segments
License
View metric
Quarterly
Annual
TTM
Segment
Q1 '26
License
$20M
Total
—